Tixagevimab and Cilgavimab Injection

Illinois rates for HCPCS M0220

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known SARS-CoV-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available COVID-19 vaccine is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s), includes injection and post administration monitoring

Rates data updated July 2026.

How much rates vary

Facilitymedian $1,202 · 10th to 90th $457 to $2,291

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High
BCBS Setting Facility Modifier Global Typical Low $457.09 Median $1,202.26 Typical High $2,290.87	Facility	Global	$457.09	$1,202.26	$2,290.87
United Setting Facility Modifier Global Typical Low $151.36 Median $151.36 Typical High $151.36	Facility	Global	$151.36	$151.36	$151.36